# China Medical University

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/china-medical-university/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 45.4 |
| Citations | 3,057,331 |
| City | Taichung |
| Country | TW |
| Description | China Medical University is a research organisation in Taichung, TW. OpenAlex records 50,451 works and 3,057,331 citations for it. 11,604 researchers list it as their most recent affiliation. |
| Homepage | http://english.cmu.edu.tw/ |
| OpenAlex ID | https://openalex.org/I184693016 |
| Researchers | 11,604 |
| ROR ID | https://ror.org/00v408z34 |
| Type | education |
| Wikidata ID | https://www.wikidata.org/wiki/Q706177 |
| Works | 50,451 |

## University papers

Showing 12 of 138.

- [Natural products in drug discovery: advances and opportunities](https://scholariq.org/papers/natural-products-in-drug-discovery-advances-and-opportunities/)
- [Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer](https://scholariq.org/papers/distinct-populations-of-cancer-stem-cells-determine-tumor-growth-and-metastatic/)
- [Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/durvalumab-plus-platinum-etoposide-versus-platinum-etoposide-in-first-line/)
- [Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis](https://scholariq.org/papers/association-between-helicobacter-pylori-eradication-and-gastric-cancer-incidence/)
- [Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/durvalumab-with-or-without-tremelimumab-plus-platinum-etoposide-versus-platinum/)
- [Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/ramucirumab-plus-erlotinib-in-patients-with-untreated-egfr-mutated-advanced-non/)
- [Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis](https://scholariq.org/papers/long-term-outcomes-of-autoimmune-pancreatitis-a-multicentre-international/)
- [Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study](https://scholariq.org/papers/durvalumab-as-third-line-or-later-treatment-for-advanced-non-small-cell-lung/)
- [Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy](https://scholariq.org/papers/removal-of-n-linked-glycosylation-enhances-pd-l1-detection-and-predicts-anti-pd/)
- [Ozone, Particulate Matter, and Newly Diagnosed Alzheimer's Disease: A Population-Based Cohort Study in Taiwan](https://scholariq.org/papers/ozone-particulate-matter-and-newly-diagnosed-alzheimer-s-disease-a-population/)
- [The role of STAT3 in leading the crosstalk between human cancers and the immune system](https://scholariq.org/papers/the-role-of-stat3-in-leading-the-crosstalk-between-human-cancers-and-the-immune/)
- [Clinical Profile of Autoimmune Pancreatitis and Its Histological Subtypes](https://scholariq.org/papers/clinical-profile-of-autoimmune-pancreatitis-and-its-histological-subtypes/)

## University researchers

- [Bing‐Fang Hwang](https://scholariq.org/researchers/bing-fang-hwang/)
- [Cheng‐Li Lin](https://scholariq.org/researchers/cheng-li-lin/)
- [Wei‐Chih Liao](https://scholariq.org/researchers/wei-chih-liao/)
- [Te‐Chun Hsia](https://scholariq.org/researchers/te-chun-hsia/)
- [Chih‐Yen Tu](https://scholariq.org/researchers/chih-yen-tu/)
- [Yi‐Hsing Chen](https://scholariq.org/researchers/yi-hsing-chen/)
- [I‐Ching Chou](https://scholariq.org/researchers/i-ching-chou/)
- [Chau‐Ren Jung](https://scholariq.org/researchers/chau-ren-jung/)
- [Shinn‐Jye Liang](https://scholariq.org/researchers/shinn-jye-liang/)
- [Yi‐Cheng Shen](https://scholariq.org/researchers/yi-cheng-shen/)
- [Liang‐Wen Hang](https://scholariq.org/researchers/liang-wen-hang/)
- [Syuan‐Yu Hong](https://scholariq.org/researchers/syuan-yu-hong/)
- [You‐Cian Lin](https://scholariq.org/researchers/you-cian-lin/)
- [C.N. Ho](https://scholariq.org/researchers/c-n-ho/)
- [Jiunn-Miin Lin](https://scholariq.org/researchers/jiunn-miin-lin/)

## University top topics

Showing 8 of 22.

- [Fractional Differential Equations Solutions](https://scholariq.org/topics/fractional-differential-equations-solutions/)
- [Nanofluid Flow and Heat Transfer](https://scholariq.org/topics/nanofluid-flow-and-heat-transfer/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Natural product bioactivities and synthesis](https://scholariq.org/topics/natural-product-bioactivities-and-synthesis/)
- [Heat Transfer Mechanisms](https://scholariq.org/topics/heat-transfer-mechanisms/)
- [Air Quality and Health Impacts](https://scholariq.org/topics/air-quality-and-health-impacts/)
- [Acupuncture Treatment Research Studies](https://scholariq.org/topics/acupuncture-treatment-research-studies/)
- [Hepatitis C virus research](https://scholariq.org/topics/hepatitis-c-virus-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.